Tenet Healthcare (NYSE:THC) Given New $342.00 Price Target at Leerink Partners

Tenet Healthcare (NYSE:THC – Free Report) had its price target upped by Leerink Partners from $309.00 to $342.00 in a research report report published on Monday,Benzinga reports. They currently have an outperform rating on the stock.

THC has been the topic of several other reports. Wells Fargo & Company lifted their price target on shares of Tenet Healthcare from $281.00 to $321.00 and gave the stock an “overweight” rating in a report on Monday. The Goldman Sachs Group reiterated a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. Robert W. Baird raised their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 28th. Stephens restated an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. Finally, Piper Sandler set a $308.00 target price on Tenet Healthcare in a research report on Monday, July 27th. Eighteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $285.89.

Read Our Latest Stock Report on Tenet Healthcare

Tenet Healthcare Stock Performance

THC stock opened at $268.89 on Monday. The firm has a market cap of $21.65 billion, a price-to-earnings ratio of 7.80, a PEG ratio of 1.02 and a beta of 1.20. The firm has a 50-day simple moving average of $264.61 and a two-hundred day simple moving average of $220.69. Tenet Healthcare has a one year low of $157.58 and a one year high of $283.05. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. The firm had revenue of $6.28 billion for the quarter, compared to the consensus estimate of $5.49 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.70 EPS. On average, equities analysts forecast that Tenet Healthcare will post 21.98 EPS for the current fiscal year.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director J. Robert Kerrey sold 12,010 shares of the firm’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $263.72, for a total value of $3,167,277.20. Following the completion of the transaction, the director owned 4,794 shares of the company’s stock, valued at approximately $1,264,273.68. This trade represents a 71.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Lisa Y. Foo sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the sale, the executive vice president owned 8,053 shares of the company’s stock, valued at $2,144,674.96. The trade was a 74.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 106,484 shares of company stock worth $28,898,063 in the last 90 days. 0.97% of the stock is owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds have recently made changes to their positions in the company. Heritage Family Offices LLP acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $98,000. Syverson Strege & Co acquired a new stake in Tenet Healthcare during the third quarter valued at $203,000. Kestra Advisory Services LLC grew its position in Tenet Healthcare by 211.3% during the third quarter. Kestra Advisory Services LLC now owns 18,898 shares of the company’s stock valued at $4,830,000 after buying an additional 12,827 shares during the period. Commonwealth Equity Services LLC increased its holdings in Tenet Healthcare by 13.6% in the third quarter. Commonwealth Equity Services LLC now owns 5,232 shares of the company’s stock valued at $1,337,000 after buying an additional 626 shares in the last quarter. Finally, Kestra Private Wealth Services LLC purchased a new position in Tenet Healthcare in the third quarter valued at $232,000. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.

Further Reading

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.